Latest Manufacturing News

Almonty Industries reported a strong net income in Q3 2025, driven by a significant non-cash warrant gain, while advancing the ramp-up of its flagship Sangdong Mine amid rising tungsten demand.

Almonty Industries posted a strong Q3 net income driven by rising tungsten prices and strategic financing, while advancing its flagship Sangdong Mine and acquiring new US exploration rights.

Theta Gold Mines has placed a pivotal order for two Titan GDM3065 ball mills, marking a significant step forward in the TGME gold plant construction in South Africa, with commissioning targeted by the end of 2026.

Northern Minerals has raised $60.5 million through a placement to institutional investors, aiming to fast-track its Browns Range heavy rare earths project and repay existing debt.

Bioxyne Limited, through its subsidiary Breathe Life Sciences, has inked an exclusive deal to import, manufacture, and distribute Curaleaf’s Que Medical Inhalation Device in Australia, with a nationwide launch set for November 2025.

Locksley Resources has received a non-binding Letter of Interest from the U.S. Export-Import Bank indicating potential financing support of up to US$191 million for its Mojave Project, aligning with U.S. efforts to rebuild domestic critical minerals supply chains.

Aquirian Limited has completed a strategic review of its Wubin Energetics Precinct and entered a framework agreement with Hongda Civil Blasting Group to establish a joint venture for an automated electronic detonator facility in Western Australia.

ResMed Inc. reported a robust 9% increase in net revenue for Q1 FY2026, driven by strong demand in its Sleep and Breathing Health and Residential Care Software segments. Despite ongoing patent litigation, the company delivered a 12% rise in net income and boosted shareholder returns with a $150 million share repurchase.

FBR Limited unveiled its new DST-enabled Mantis welding robot targeting heavy fabrication sectors while completing key milestones on its Hadrian bricklaying technology and securing a $22 million financing package.

ClearVue Technologies has secured a $4.6 million capital raise and signed major partnerships, setting the stage for commercialisation in 2026 with a robust $60 million project pipeline.

Argent BioPharma has secured a transformative acquisition of AusCann’s core assets, bolstering its drug delivery technology and manufacturing capabilities ahead of a planned U.S. listing. The company also reported key clinical milestones and refinancing moves in its September 2025 quarterly update.

PARKD Limited has raised $1 million to fund its East Coast expansion, secured a new prefabrication facility in NSW, and landed its first pilot project with McNab Group, marking a pivotal step in its national rollout.